Article
The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.
Gene therapy - 1 Jun 2015
Herrera-Carrillo E, Berkhout B
Abstract excerpt
A hurdle for human immunodeficiency virus (HIV-1) therapy is the genomic diversity of circulating viruses and the possibility that drug-resistant virus variants are selected. Although RNA interference (RNAi) is a powerful tool to stably inhibit HIV-1 replication by the expression of antiviral short hairpin RNAs (shRNAs) in transduced T cells, this approach is also vulnerable to pre-existing genetic variation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
